The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

Spread the love“`html In a competitive job market, especially in the tech industry, having a standout resume is crucial. With hiring processes becoming more stringent, tech job seekers must leverage ...